![ISPOR Europe 2024 – May 5-8. Register now.]({"type":"image" , "src" : "/sda/112342/JournalAd-ISPOR-2024-Leaderboard.jpg"})
Citations (9)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Carla Dias Barbosa, Maria-Magdalena Balp, Károly Kulich, Nicola Germain & Diana Rofail. (2012) A literature review to explore the link between treatment satisfaction and adherence, compliance, and persistence. Patient Preference and Adherence 6, pages 39-48.
Read now
Read now
Lorne E. Aaron, Thomas J. Morris, Paulette Jahshan & Joseph L. Reiz. (2012) An evaluation of patient and physician satisfaction with controlled-release oxybutynin 15 mg as a one-step daily dose in elderly and non-elderly patients with overactive bladder: results of the STOP study. Current Medical Research and Opinion 28:8, pages 1369-1379.
Read now
Read now
Articles from other publishers (7)
Kwang Jin Ko, Myung‐Soo Choo, Young‐Seop Chang, Joon Chul Kim & Kyu‐Sung Lee. (2020) A multicenter prospective study for overactive bladder patient treatment satisfaction with mirabegron after being unsatisfied with antimuscarinic therapy (FAVOR study). Neurourology and Urodynamics 39:8, pages 2417-2424.
Crossref
Crossref
Hironobu Akino, Mikio Namiki, Koji Suzuki, Hideki Fuse, Yasuhide Kitagawa, Katsuhito Miyazawa, Yasuyoshi Fujiuchi & Osamu Yokoyama. (2014) Factors influencing patient satisfaction with antimuscarinic treatment of overactive bladder syndrome: Results of a real-life clinical study. International Journal of Urology 21:4, pages 389-394.
Crossref
Crossref
Norman Zinner, Kathleen Kobashi, Patricia Koochaki, Deborah Fix & Mathias Egermark. (2011) Patient satisfaction with the benefits of overactive bladder treatment: Exploration of influencing factors and development of a satisfaction assessment instrument. Neurourology and Urodynamics 30:1, pages 62-68.
Crossref
Crossref
S.T. Mahajan, P.B. Patel & R.A. Marrie. (2010) Under Treatment of Overactive Bladder Symptoms in Patients With Multiple Sclerosis: An Ancillary Analysis of the NARCOMS Patient Registry. The Journal of Urology 183:4, pages 1432-1437.
Crossref
Crossref
Roger R. Dmochowski, Matt T. Rosenberg, Norm R. Zinner, David R. Staskin & Peter K. Sand. (2010) Extended-Release Trospium Chloride Improves Quality of Life in Overactive Bladder. Value in Health 13:2, pages 251-257.
Crossref
Crossref
Setareh A. Williams, Samuel Wagner, Hema Kannan & Susan C. Bolge. (2009) The Association Between Asthma Control and Health Care Utilization, Work Productivity Loss and Health-Related Quality of Life. Journal of Occupational & Environmental Medicine 51:7, pages 780-785.
Crossref
Crossref
Peter Dwyer, Con Kelleher, Jay Young, François Haab, Karine Lheritier, Rinat Ariely & Ursula Ebinger. (2008) Long‐term benefits of darifenacin treatment for patient quality of life: Results from a 2‐year extension study. Neurourology and Urodynamics 27:6, pages 540-547.
Crossref
Crossref